Introduction
Several techniques are currently used for noninvasive medical imaging in medicine to improve the quality of diagnoses and use more precise treatments.
1,2 Magnetic resonance imaging (MRI) is a non-ionizing, non-invasive imaging technique that provides high spatial resolution and depth with pronounced so-tissue contrast for in vivo imaging. The differential contrast observed between so tissues can be adjusted by altering the data acquisition parameters. 3 Water molecules are the primary source of protons for the generation of MRI signals, although lipids can also function in this capacity. 4 Since healthy and unhealthy tissues may have different intrinsic relaxation times depending on their physiological environment, specic contrast can be observed between the site of interest and the surrounding regions at advanced stages of disease. 5 A variety of contrast agents (CAs) have been designed to enhance the diagnostic value of MRI and detect tissue abnormalities at an earlier stage, typically by shortening T 1 or T 2 relaxation times and thereby increasing r 1 (1/T 1 ) or r 2 (1/T 2 ) relaxivities. 6 These contrast agents are promising candidates for highly effective molecular imaging due to their small size and versatile functionality. While positive CAs, which are mainly gadolinium-and manganese-containing agents, lower the T 1 relaxation time and create a brighter contrast, negative CAs, which are primarily iron-based compounds, shorten the T 2 relaxation time and result in darker contrast. Because of the detrimental effects associated with the dissociation and accumulation of gadolinium and manganese ions in the body, 7 considerable research has been performed on the preparation of nontoxic formulations of these metals, as well as on the preparation of non-toxic alternatives to traditional T 1 contrast agents. Iron oxide-based CAs are one such example of low-toxicity T 2 contrast agents, as iron is naturally found in human blood and excess iron can be stored as ferritin in the body. Magnetite (Fe 3 O 4 ) nanoparticles are especially suitable as next-generation imaging agents due to their biocompatibility, biodegradability and low level of toxicity. 8, 9 These iron oxides can also display superparamagnetic properties depending on the crystal structure, size and shape of the synthesized particle, further enhancing their versatility in biomedical applications. 10 Recent advances in the development of surface modied nanoparticles have increased usage of MRI for cancer diagnosis. 11 Several groups have reported that tumor specic MRI T 2 imaging agents are biocompatible, biodegradable and have long blood circulation time, which provide high accumulation in the tumor tissue. 12, 13 As contrast agents, iron oxide nanoparticles provide several opportunities in the accurate diagnosis of cancer.
14 For example, iron oxide nanocubes encapsulated with polyethylene glycol-phospholipid have been shown to increase sensitivity in tumor imaging compared to Feridex. 15 Lee and coworkers have developed branched PEI and PEG coated SPIONs that are able to bind to negatively charged plasmid DNA due to the positive charge on their surface and are detectable at the tumor site by MRI. 16 The MRI contrast agents are administrated intravenously and their solubility and dispersity in water and serum are also essential for their applicability in biomedical applications. 17 Therefore, a diverse array of surface modication strategies were developed to increase the colloidal stability of CAs, enhance their pharmacokinetic performances and allow facile coupling of biological ligands to their surfaces. 18 Up to now, ligands possessing anchor groups such as carboxylic acids, phosphines, amines, and catechol were generally utilized to modify the surface of iron oxide nanoparticles through ligand exchange reactions, rendering them water-dispersible.
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Depending on the availability of terminal functional groups in the ligand, bioactivity can also be imparted by decorating a chemically active organic coating with different moieties such as cell penetrating or RGD peptides, 20, 21 antibodies, 22 folic acid 23 and carbohydrates. 24, 25 Alternatively, amphiphilic ligands such as PEGylated phospholipids, and PEGylated or Pluronic polymers were exploited to form organic shells around the nanoparticle core by physical encapsulation or assembly through van der Waals interactions and/or electrostatic interactions.
19 Also, coating of hydrophobic iron oxide nanoparticles with hydrophilic amphiphilic peptides were accomplished by noncovalent interactions. 26 There is a need for iron oxide-based CAs for in vivo applications.
Here, we demonstrate noncovalent coating of SPIONs with proline-rich amphiphilic peptides (SPION/K-PA), and investigated the efficiency of this superparamagnetic, waterdispersible hybrid system in enhancing the MR imaging of tumor tissue in rats. The physicochemical characteristics of SPION/K-PA was investigated through material characterization techniques, while its potential as an MRI contrast agent was assessed in both in vitro and in vivo experiments. In particular, the cellular viability and uptake behavior of the SPION/K-PA system were investigated by using human vascular endothelial cells (HUVEC) and estrogen receptor (ER) positive human breast adenocarcinoma (MCF-7) cells, while the biodistribution and bioelimination of the nanocomposites were investigated by MRI and histological examination in a rat breast cancer model. The contrast of the MR image of tumor tissue was enhanced by SPION/K-PA. MRI and biodistribution studies conrmed the feasibility of SPION/K-PA for in vivo tumor imaging.
Experimental section
Materials 1-Dodecylamine (98%) and iron(III) 2,4-pentanedionate (97%) (Fe(acac) 3 ) were purchased from Alfa Aesar. 1,2-Hexadecanediol was purchased from Sigma-Aldrich. Lauric acid and triuoro-acetic acid (TFA) were purchased from Merck. Chemicals required for peptide synthesis, such as 9-uorenylmethoxy-carbonyl (Fmoc), tert-butyloxycarbonyl (Boc) protected amino acids, [4- 
?acetamidonorleucyl-MBHA resin (Rink amide MBHA resin) and 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexauoro-? ?phosphate (HBTU) were purchased from NovaBiochem. All reagents and solvents were used as received. Water used during the experiments was deionized by a Millipore Milli-Q purier system and had a resistance of 18 MU cm.
Synthesis of superparamagnetic iron oxide particles
Superparamagnetic nanoparticles were synthesized according to a previously described procedure with minor modications.
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Briey, 6 mmol (1.112 g) lauric acid, 6 mmol (1.2 g) laurylamine and 10 mmol (2.584 g) 1,2-hexadecanediol were mixed in 20 mL of dibenzylether and heated. When the reaction medium reached 200 C, 2 mmol (0.706 g) Fe(acac) 3 was added and the sample was stirred for 1-1.5 h at 200 C under inert atmosphere.
A condenser was added to the setup for reux and the system was moved to a hot jacket heater to increase the temperature to 300 C. Following 1 h of stirring at this temperature, the mixture was allowed to cool to room temperature and 50 mL ethanol was added under air. The mixture was centrifuged at 8000 rpm for 15 min, the supernatant was removed and 2-3 mL of hexane was added to the pellet. Aer 1 min of sonication, 20-30 mL ethanol was added to the mixture. Lastly, the sample was centrifuged again and the brownish supernatant was discarded. Ethanol addition, centrifugation and decantation steps were repeated until the supernatant was observed to exhibit a clean color. The colorless supernatant was then discarded and 6-7 mL hexane was added to the pellet. Superparamagnetic iron oxide nanoparticles were obtained by sonication for 5 min followed by centrifugation for 10 min at 6000 rpm, and stored at 4 C. was then added to the peptide solution during the sonication process. Amphiphilic peptide molecules and SPIONs were mixed at a weight ratio of 7 : 1 and a volume ratio of 10 : 1, respectively. Aer 1 h of repeated sonication and vortexing steps at indicated temperature range, the solution was puried by centrifugation at 6500 rpm for 5 min, using ultraltration tubes with 50 kDa cut-off membranes (Millipore Amicon UltraRegenerated Cellulose). This step was repeated at least 2 times.
Characterization of SPIONs and hybrid SPION-peptide system
Morphological characterization. TEM was performed using a FEI Tecnai G2 F30. 10 mL of 50-fold diluted, PA-functionalized and non-functionalized SPION samples were placed on a carbon lm (300 mesh) coated copper grid and incubated for 5 min. The excess solution was then removed by pipetting, and the grids were dried under fume hood at room temperature for over 2 h. Selected area electron diffraction (SAED) patterns of hydrophobic SPIONs were taken at an accelerating voltage of 200 kV by TEM. Nanoparticle diameters were determined by using Image J soware from at least 100 nanoparticles.
X-ray diffractometry analysis. Crystal structures of magnetite nanoparticles were investigated by a PANalytical X'Pert Powder Diffractometer operating at 45 kV and 40 mA. Analyses were performed under Cu Ka radiation (l ¼ 0.15418 nm) in the range of 2q ¼ 10-80
. Lyophilized powders were grinded before the analysis and dispersed homogeneously into the holder. All XRD patterns were smoothed and backgrounds were subtracted by using instrument's soware (X'Pert High Score). Chemical characterization by infrared spectroscopy. FTIR analysis was carried out using a Bruker VERTEX 70 with Hyperion scanning to conrm the presence of both iron oxide nanoparticles and the organic coating layer. Prior to the pellet preparation, all samples were lyophilized or dried in a vacuum oven (Memmert GmbH + Co. KG, Germany). SPION, SPION/K-PA and K-PA samples were then mixed with KBr (1 : 99 (w/ w%)), pelleted by grinding and analyzed at a wavelength range of 400-4000 cm À1 .
Thermogravimetric analysis. Thermal gravimetric analyses (TGA) were performed using Perkin-Elmer TGA to analyze the organic/inorganic composition of SPION/K-PA samples. Sample temperature was increased from room temperature to 800 C with a heating rate of 10 C min À1 . 3-5 mg of lyohilized K-PA and SPION/K-PA samples were used for the analysis. Hydrophobic SPIONs dissolved in hexane solutions were dried in a vacuum oven (Memmert GmbH + Co. KG, Germany) prior to measurement. Particle size and zeta potential analysis. Hydrodynamic sizes and zeta potentials of the particles were measured by dynamic light scattering (DLS). A Malvern Nanosizer/Zetasizer nano-ZS ZEN 3600 (Malvern Instruments, USA) instrument with a detector angle of 173 was used for DLS analysis. Hydrophobic particles and hydrophilic particles were diluted with hexane and water, respectively, and measurements were performed in quartz cuvettes. In addition, dip cell electrodes were used in zeta potential measurements. All analyses were measured in triplicate and standard deviations were calculated from the mean of data. For experiments conducted in 5% dextrose solution at 25 C, refractive index, viscosity and dielectric constant values were assumed to be 1.34, 1.03 Pa s and 77.37, respectively. The concentration of iron oxide nanoparticles was set to 250 mg mL À1 for all experiments, and the refractive index of magnetite particles was taken as 2.42. Iron content measurement. Iron concentration was determined through inductively coupled plasma-mass spectrometry (ICP-MS, Thermo X Series II) and colorimetric Prussian blue assay prior to PA coating and in vitro and bioimaging experiments. In the former method, a standard curve was derived by dissolving and serially diluting an iron-containing plasma emission standard solution (1000 ppm, VWR-BDH Prolabo) in 2% nitric acid to obtain 500, 250, 100 and 50 ppb standard iron concentrations. SPION solutions were dissolved in concentrated nitric acid before dilution and heated up to 60 C for digestion prior to measurements. In the Prussian blue assay, a calibration curve was plotted by preparing serially diluted iron solutions (1000 ppm, VWR-BDH Prolabo) in 6 N HCl. All samples including standards and unknowns were digested at 65 C for an hour for the conversion of iron from nanoparticle form to ionic form. 160 mL HCl and 40 mL of 5% K 4 Fe[CN] 6 was then added to 160 mL of samples. Three independent repeats of each sample were prepared for measurement, and HCl and 5% K 4 Fe[CN] 6 in water was used as blank solution. Samples were allowed to stain for 20-25 min, and solution color was observed to change from yellow to blue in high-concentration samples following the reaction. UV absorbance was measured at 690 nm by using Spectramax M5 (Molecular Devices). Peptide content determination. Peptide-coated SPIONs were puried from excess amphiphilic peptide molecules by ultraltration using Millipore Microcon Centrifugal Filter Units at a cut-off point of 50k MW. SPIONs were ltered 2 to 3 times at 6500 rpm for 5 min. The eluted parts were collected at each step and peptide concentrations were measured by NanoDrop 2000 (Thermo Scientic). Results were compared with the results obtained from samples prepared with known amounts of PAs. Peptide quantication method offered by Thermo Scientic was utilized to measure the absorbance at analysis wavelength of 205 nm with an extinction coefficient of 31 mg mL À1 at 1 cm path length. 
small diameter of tumor). 30 MRI measurements were performed when tumor volumes reached 100 mm. Histological analysis was performed on tissues obtained from the harvested organs, and their general appearances, clearance proles and tissue distributions were evaluated to further analyze the in vivo biosafety and efficiency of SPION/K-PA. Animals were euthanized aer the completion of MR imaging. Mammary tumor, liver, spleen, and kidneys were dissected and xed overnight in 10% formalin, embedded in paraffin, sectioned with a Leica microtome (5 mm thickness), and stained with hematoxylin and eosin as described elsewhere. 31 Iron deposits were identied using standard Prussian blue staining protocol. Histological sections were observed under optical microscopy.
Statistical analysis. All data are presented as AEstandard error of mean (SEM) for all in vitro and in vivo results. Plotting was performed using the GraphPad Prism 5 soware (La Jolla, CA). Viability results were evaluated using one-way analysis of variance (ANOVA) with Tukey's test for group-wise comparisons. MRI results were compared by two-way ANOVA test. p values less than 0.05 were considered as statistically signicant.
Results and discussion

Synthesis and characterization of the nanoparticles
Thermal decomposition is an effective method for the production of iron oxide nanoparticles with minimal variance in shape and size. 27 Although the method results in the formation of water insoluble nanoparticles and requires further modication for the efficient dispersion in the aqueous environment, it provides higher stability and signicant control over the size and shape of the nanoparticle compared to co-precipitation, which is another common method for nanoparticle synthesis. 32 Here, iron oxide (Fe 3 O 4 ) nanocrystals were synthesized through the high-temperature reaction of iron(III) acetylacetonate, Fe(acac) 3 , in dibenzyl ether in the presence of 1,2-hexadecanediol, lauric acid and dodecylamine. Since the produced nanoparticles were hydrophobic due to their lauric acid and dodecylamine capping, they were dispersed in a nonpolar organic solvent, hexane. Subsequently, they were stored at 4 C and used for further modication in the course of six months. The iron oxide nanoparticles, which were prepared via thermal decomposition method, had an average size of 4-16 nm and displayed superparamagnetic characteristics. 33 In our previous study, this behavior was veried by vibrating sample magnetometer (VSM) measurements. 26 We furthermore observed that the synthesized superparamagnetic iron oxide nanoparticles (SPIONs) possessed rapid magnetic responsivity to an applied external magnetic eld (Fig. S1 †) . TEM images (Fig. 1c) suggest that monodisperse SPIONs had a narrow size distribution with uniform spherical morphologies. Their average diameter was found to be 5.5 nm, with a standard deviation of 0.6 nm. Dynamic light scattering (DLS) analysis was also performed on hexane-dispersed nanoparticles, diameters of which were found to be 7.1 AE 0.3 nm and were in agreement with the diameter values obtained from imaging (Fig. S2 †) . Lattice fringes can be observed in the high resolution transmission electron microscopy (HR-TEM) image of SPIONs (Fig. 1a and b) , demonstrating the crystallinity of the respective nanoparticles. A specied area was magnied from the image to visualize individual lattice planes to a greater extent. The measured d-spacing of 2.12Å corresponded to that of the (400) plane (2.09Å) of magnetite. 34 Additionally, the circular rings present in the electron diffraction pattern conrmed the polycrystalline nature of the magnetite nanoparticles (Fig. 1d) . Lattice spacings corresponding to each ring were calculated based on the diffraction patterns and showed good agreement with that of magnetite (JCPDS, no. 19-0629). XRD analysis result of SPIONs was also consistent with these obtained from SAED patterns and the literature (Fig. 3a) . 35 The diffraction patterns demonstrated in Fig. 3a were used to estimate the d-spacings of SPIONs by using Bragg's law. The calculated values along with the respective Miller indices values (hkl) and reference data are listed in Table S1 . † Results acquired from these techniques supported each other and revealed that the synthesized SPIONs had an inverse spinel structure.
34
A variety of methods are available to increase the watersolubility and enhance the dispersion stability of SPIONs in physiological conditions, the optimization of which is critical for the in vivo applicability of nanoparticles. Principal among these methods are the ligand addition or ligand exchange approaches. 36 In the former method, noncovalent interactions, such as electrostatic interactions, hydrophobic interactions and hydrogen bonding, are the major driving forces for the physical adsorption of molecules to the surface of SPIONs. Amphiphilic macromolecular ligands and liposomes have been used for the preparation of water-dispersible SPIO nanocomposites. 19, 37 In this study, to improve the biocompatibility and biodegradability of the functionalized SPIONs, PA molecules were utilized in the production of SPION/PA nanocomposites. In the amphiphilic peptide design, three main segments were used for the development of stable, well-dispersed SPION/PA system. While alkyl tail of peptide enhancing the hydrophobic interactions between alkylated surface of SPIONs and peptide, the proline-rich segment (-PPP) with its hydrogen bond breaking property improves intermolecular cohesive interactions by avoiding nanober formation, and lastly charged amino acid residue is used to solubilize the system as well as to prevent its aggregation. Proline-rich amphiphilic peptides are known to exhibit random coil conformations, as analyzed by circular dichroism. 38, 39 The PA was synthesized by solid phase peptide synthesis strategy based on orthogonal protection/deprotection chemistry, and its chemical structure was veried by liquid chromatography and mass spectroscopy (Fig. S3 †) . The change in the design led to an increase in the integration of the lauryl group of the PA into the alkylated surface of SPIONs, resulting in enhanced solubility in aqueous environment. The water stabilization of SPIONs was achieved by simply sonicating two immiscible solutions at the temperature range of 55-65 C, below the boiling point of hexane. While SPIONs transferred into the water phase, hexane slowly evaporated with time. Aer the purication steps, the nanoparticles were concentrated through the ultraltration method. As shown in Fig. 2 , SPIONs were successively transferred into the aqueous environment with this method. The eluted parts were also collected to indirectly determine the amount of peptide in the SPION/K-PA coassembled system. Excess peptide amount was calculated by measuring peptide bond absorption at 205 nm. 28 Since PA molecules were not purely composed of amino acids but also contained an alkylated "tail" region, we primarily normalized the values by measuring known amount of peptide samples prepared at different concentrations. Aer normalization, the value was subtracted from the initial peptide amount used for the SPION functionalization. According to the calculations, nearly 35% of initial peptide remained in the co-assembled system. SPION/K-PA can be stored at high concentrations in the refrigerator for 4-5 months without losing its water dispersibility and magnetic responsivity.
The SPION/K-PA system was further examined by using a variety of material characterization techniques. The XRD pattern of pure amphiphilic peptides showed a diffused halo peak registered between 10 and 30 (2q), revealing the amorphous nature and conrming the disorganized structure of PAs (Fig. 3a) . The SPION/PA nanocomposite exhibited the same diffraction pattern as those obtained before PA functionalization, indicating that SPIONs retained their crystal structure aer being assembled with PAs. FTIR spectra of non-bound PAs, SPIONs and their co-assembled form are presented in Fig. 3b . Hydrophobic SPIONs showed two prominent bands at 596 and 438 cm À1 which were attributed to the Fe-O vibrations of the ferrite core. 40 The peaks at 2926 and 2848 cm À1 were attributed to the asymmetric and symmetric stretching vibrations of -CH 2 groups present in lauric acid and dodecyl amine. Two peaks were observed at 1526 and 1413 cm À1 , corresponding to two carboxylate stretches that may be related to the chemisorption of lauric acids on the surface of nanoparticles. In the case of PA molecules, characteristic C]O stretching vibrations were observed between 1600 and 1700 cm À1 , while N-H bending vibrations were found to generate a broad band at 3200-3600 cm À1 . The IR spectrum of K-PA also exhibited C-N stretching and N-H bending vibration peaks at around 1534 cm À1 corresponding to the amide II band of PA. In the co-assembled form, the previously identied peaks of SPION and PA were both present. Additionally, the strength of -CH 2 stretching at 2926 and 2848 cm À1 increased with the integration of the alkyl tail of peptide into the system. TGA thermograms were obtained to determine the organic/ inorganic ratio of SPION/PA system and the corresponding decomposition temperatures. SPIONs showed two major transitions prior to PA functionalization, with weight losses occurring between 200-450 C and 600-750 C. These losses most likely resulted from the decomposition of the organic surface layer and phase transition from Fe 3 O 4 to FeO followed by the deoxidation of FeO, respectively (Fig. S4a †) . 41 In the case of K-PA, the rst pronounced mass loss was observed at 220 C due to the decomposition of the alkyl tail, and a second mass loss between 300 and 450 C was ascribed to the cleavage of peptide bonds and amino acid side groups. Aer PA functionalization, similar decomposition processes were observed, and a total mass of 52% was found to be attributable to PAs (Fig.-S4b †) . Results acquired from TGA analysis also corroborated with the results obtained from the colorimetric PA determination analysis. As shown in Fig. S5 , † the peptide functionalization process did not change the shape of the nanoparticles, which were randomly distributed on the TEM grid except for very few overlapping areas. Since there was no staining on the samples, only the core was imaged and the mean diameter of the SPION/K-PA nanoparticles was estimated as 5.3 AE 0.7 nm, revealing that functionalization did not cause any change in the morphology of nanoparticles in terms of shape or size. When the hydrodynamic size of SPION/K-PA was determined in two different media, water and 5% dextrose solution, nanoparticles were found to have hydrodynamic sizes of 58.0 AE 0.7 nm and 58.6 AE 0.1 nm in water and 5% dextrose, respectively, which are in the range of optimal values for long circulation times in vivo (Fig. S6 and Table S2 †) . 42 The hydrodynamic sizes did not signicantly change over the measured period of time for both solutions, and the photographs of nanoparticle dispersions indicated that they maintained their dispersion stabilities even aer a week (Fig. S6 †) . Nanoparticles dispersed in 5% dextrose solution exhibited smaller changes in their hydrodynamic sizes compared to those dispersed in water, which is suitable for the storage of these nanoparticles prior to their administration. Their zeta potentials were also measured and found to be positively charged due to the lysine residue present in the PA structure.
In vitro cytotoxicity and uptake studies
The biocompatibility of SPION/K-PA was evaluated on vascular endothelial cells and human breast cancer cells by using Alamar blue assay. Iron concentrations were adjusted by measuring iron contents of the solutions using two different techniques, inductively coupled plasma-mass spectrometry and colorimetric Prussian blue assay. To determine iron content via colorimetric method, a calibration curve was constructed for solutions prepared from serially diluted reference solutions (Fig. S7 †) , and PA amounts in corresponding SPION/PA solutions were spectroscopically determined. We compared the cytocompatibility proles of K-PA and SPION/K-PA to understand whether they affect the viability of tumor cells or nontumor cells (Fig. S8 †) . SPION/K-PA was found to be biocompatible for both HUVECs and MCF-7 cells aer 24 h and 48 h exposure. In the literature, dextran or citric acid coated nanoparticles were shown to demonstrate higher cytotoxicity on HUVECs at nanomolar concentrations aer 24 h of exposure.
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When compared to those nanoparticles, SPION/K-PA is safer for biomedical applications at tested concentrations (Fig. S8 †) . On the other hand, cytotoxicity assay results also showed that K-PA alone affects cell viabilities in a dose-dependent manner which may result from the presence of positively-charged side chains on the surfaces of unbound peptides that may increase their interactions with the cell membrane, resulting in membrane damage. 44 Prior to in vivo studies, the biocompatibility of the nanoparticles was further analyzed using live-dead assay. For in vitro studies, selected concentration (75 mg mL À1 ) is equivalent of MR administration dosage which was calculated according to the total circulating blood volume of a rat (64 mL kg À1 of body weight). 45 The data in Fig. 4a and b indicate that there was no considerable reduction in vascular cell viability aer exposure to K-PA and SPION/K-PA compared to the no-treatment group. More than 90% of the cells survived in the presence of SPION/K-PA aer 24 h of incubation, suggesting that these nanoparticles could be employed safely in MRI.
The cellular uptake of nanoparticles by endothelial cells was visualized by Prussian blue staining. Clustered blue particles were present on the surfaces and interiors of HUVECs exposed to SPION/K-PA (Fig. 4c) . Nanoparticles were retained in cells within 6 h. The binding efficiency of SPION/K-PA reached approximately 90% for HUVECs. Under the same conditions, no blue dots were observed in non-treated control cells. The strong binding interaction exhibited by SPION/K-PA may result from the electrostatic interactions between the positively charged nanoparticles and the cells, which possess a negatively charged phospholipid membrane. It is known that positively charged nanoparticles have higher uptake rates than negatively charged particles.
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In vivo magnetic resonance imaging studies
We evaluated the capacity of the SPION/K-PA to serve as a negative contrast agent in T 2 -weighted MRI in vivo by using chemically induced model of breast cancer. DMBA is a well known carcinogen which leads to the release of lipid peroxides and formation of free radicals to induce tumorigenesis. Palpable mammary tumors were developed in DMBA treated animals aer 12 weeks. Relative signal intensity (SI) of nanoparticles in tumors, healthy breast tissue and RES organs were determined as a function of time for up to 15 days aer contrast agent injection through the tail vein, using a clinical 1.5 T MRI system with a T 2 -weighed m-GRASE sequence.
MRI results showed that the nanoparticles preferentially accumulated in tumor tissue rather than RES organs. Signi-cant negative enhancement of the MRI signal for SPION/K-PA in the tumor tissue was observed from 1 h to 4 h, compared to the T 2 -weighted images prior to the administration of SPION/K-PA and non-injected control groups (Fig. 5a ). Signal intensity changes resulting from nanoparticle uptake into tumor and other organs were calculated in the region of interest (RIO) of the T 2 -weighted m-GRASE images as a function of time in order to quantify signal contrast enhancement (Fig. 5b) . Importantly, signal intensities of mammary tumors decreased by approximately 45% and 65% at 1 h and 4 h aer SPION/K-PA injection, respectively. These results conrmed that SPION/K-PA could serve as an effective negative contrast agent for the diagnosis of cancer by MRI. Additionally, there was no statistically considerable difference between the organs of healthy and tumorbearing animals in terms of the signal drop in breast and RES organs following the administration of nanoparticles. Relative SIs were observed to be reduced in the liver, kidney and spleen of both healthy and tumor-bearing animals immediately following nanoparticle administration, which may be a consequence of the fast blood ow rate in these organs. 48 Nevertheless, the signal intensity of magnetic nanoparticles in RES organs started to increase to the same levels as the pre-injection groups at 1 h (Fig. 5b) . Compared to the T 2 values measured using pre-contrast images, the particles did not produce a T 2 shortening aer 15 days in any organ. This indicated that nanoparticles were removed from the organs within two weeks.
Though SPION/PA does not possess any targeting ligands on its surface, it can efficiently accumulate in tumors because of the leaky vascular structure of tumor tissue, which is referred to enhanced permeation and retention (EPR) effect. Using this phenomenon, SPIONs have been previously utilized for in vivo cancer imaging via MRI in the absence of a biologically active targeting ligand. 15, 49 However, there is a distinct lack of information regarding the elimination routes and times of retention associated with SPIONs in different organs. We further studied the accumulation and retention of SPIONs in different organs by using histological analyses.
Histological examination and tissue distribution of SPION/K-PA
We examined the short and long-term distribution of SPION/ K-PA within the tissue sections of rats aer nanoparticle injection. RES organs are usually the main site of accumulation for nanoparticles. Nanoparticle aggregation at these locales may cause inammation, release of toxic byproducts by biodegradation or uncontrolled and unpredictable patterns of localization. In addition, prolonged nanoparticle exposure may result in hematopoietic, bone marrow and/or renal toxicity. 50 In particular, the inltration of monocytes and lymphocytes through the portal space or centrolobular veins is the most important indicator of the inammatory process in liver. 51 There was no obvious pathological changes and any lesions in the liver and the number of lymphocytes did not alter in the spleen of both healthy and tumor-bearing rats aer nanoparticle injection (Fig. S9 and S10 †) . Additionally, shortened tube cavity, atrophy of the renal tubular and glomerular epithelial cells, and transparent tubes were not observed in the kidney of experimental groups. These results demonstrated that exposure to SPION/K-PA does not result in inammation or systemic toxicity not only in short term but also at two weeks post-injection.
To further verify the accumulation and distribution of SPION/K-PA in tumors and harvested organs, Prussian blue staining was carried out as shown in Fig. 6 , S11 and S12. † We detected a large number of blue dots in the tumors of rats administered with SPION/K-PA, which indicates the elevated uptake of nanoparticles in tumor tissue. Prussian blue staining of liver, spleen and kidney tissues in the SPION/K-PA group revealed no signicant uptake of nanoparticles in both healthy and cancerous rats aer 4 h. These results are in accordance with those we obtained by MRI.
When designing an effective nanomaterial for diagnostic applications, one of the most important issues is to increase the material's residence time in the organ of interest and thereby allow imaging to be performed for as long as possible prior to its clearance. However, the material should also be broken down and removed from the body aer imaging to prevent its cumulative accumulation.
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Taken together, our results demonstrated that SPION/K-PA is biocompatible and biodegradable, while localizing into the tumor site and allowing enhanced MRI imaging following injection. 53 
Conclusion
In summary, we show peptide coated iron oxide nanoparticles in aqueous environment. The MRI signal of breast tumor tissue was signicantly enhanced aer administration of the SPION/K-PA, which shows that the nanocomposite system is promising as a negative MRI contrast agent. The in vivo observation of SPION/K-PA suggest that the co-assembled system is biocompatible and biodegradable, as conrmed by the long-term consistency of the MRI signal and the material's lack of accumulation in RES organs in histological analyses. Due to the ease of functionalization of the nanoparticles, the practical use of peptide functionalized SPIONs can be further extended by conjugating bioactive epitopes into the peptide construct to selectively target a specic type of receptor or cell. 
